Home › Funds › Propel Bio Management, LLC › IRD
Propel Bio Management, LLC position in IRD
OPUS GENETICS INC · Health Care
Propel Bio Management, LLC reported holding 270,036 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.69% of its reported portfolio and ranking #27 among its reported holdings. Propel Bio Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's IRD position evolved
Propel Bio Management, LLC first disclosed a stake in IRD in Q3 2026 at 270,036 shares (US$1.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 270.04K | $1.31M | New |
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 74 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- Caligan Partners LP 6.08M sh · $24.98M · Q2 2026
- BIOS Capital Management, LP 3.68M sh · $15.14M · Q2 2026
- Boxer Capital Management, LLC 2.81M sh · $11.57M · Q2 2026
- Trails Edge Capital Partners, LP 2.74M sh · $11.28M · Q2 2026
- GREAT POINT PARTNERS LLC 1.97M sh · $8.10M · Q2 2026
- Blue Owl Capital Holdings LP 969.61K sh · $4.69M · Q3 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- Mink Brook Asset Management LLC 161.21K sh · $662.55K · Q2 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held IRD?
Propel Bio Management, LLC has disclosed IRD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Propel Bio Management, LLC's current position in IRD?
As of Q3 2026, Propel Bio Management, LLC holds 270.04K shares of IRD (OPUS GENETICS INC), valued at $1.31M, representing 0.69% of its reported portfolio and ranking #27.
Has Propel Bio Management, LLC been buying or selling IRD?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC newly opened its position in IRD.
Which other funds hold IRD?
Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 74 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.